Related references
Note: Only part of the references are listed.Mutational landscape of gray zone lymphoma
Clementine Sarkozy et al.
BLOOD (2021)
Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database
Theodoros P. Vassilakopoulos et al.
LEUKEMIA RESEARCH (2021)
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases
Guillaume Aussedat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study
Yoshitoyo Kagami et al.
CANCER SCIENCE (2020)
Long-term Remission by Brentuximab Vedotin for Non-mediastinal Gray Zone Lymphoma Refractory to Autologous Stem Cell Transplantation
Kazutoshi Ebisawa et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin
Jamilla Li et al.
ANNALS OF HEMATOLOGY (2018)
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort
Andrew M. Evens et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
Eric D. Jacobsen et al.
BLOOD (2015)
A prospective study of mediastinal gray-zone lymphoma
Wyndham H. Wilson et al.
BLOOD (2014)
Mediastinal gray zone lymphoma - The missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma
A Traverse-Glehen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Share Paper
